Existing Peer Review Literature, Links NAD+ To Longevity

Since the 1970s, scientists have been discovering that many chronic conditions actually begin in cells that aren’t metabolising effectively. Many of these (mitochondrial basis) diseases have been successfully treated with NAD+ IV Therapy. By age 40, levels of NAD+ have declined by 50%. This jumps to 80% by age 60. We also know that NAD+ can help protect us from free radicals – unstable atoms that influence ageing and disease. All of this means boosting your levels of NAD+ needs to be a top priority in optimising mental and physical human performance.